Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT03625401 · UNKNOWN
Trial details
- NCT number
- NCT03625401
- Sponsor
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-04
- Primary completion
- 2020-12-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.